TUSC3 Antibody

1. miR-UL112-3p exerts its oncogene function by directly targeting TUSC3 in Glioblastoma. PMID: 28303930
2. study demonstrated an oncogenic role of TUSC3 in Non-small cell lung cancer and showed that dis-regulation of TUSC3 may affect tumour cell invasion and migration through possible involvement in the Hedgehog (Hh) signalling pathway. PMID: 28487226
3. TUSC3 may act as an oncogene in the progression of colorectal cancer. PMID: 30115537
4. TUSC3 can function both as an oncogene and as a tumor suppressor. (Review) PMID: 28929175
5. our data indicate that miR-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting TUSC3 in glioblastoma. PMID: 28901390
6. This paper supports the previous clinical descriptions of the condition caused by TUSC3 mutations and describes the seventh family with mutations in this gene, thus contributing to the genetic spectrum of mutations. This is the first report of a family from the Arabian peninsula with this form of Intellectual disability . PMID: 27148795
7. SOX2 regulates the proliferation, migration and invasiveness of breast cancer cells through miR-181a-5p and miR-30e-5p which modulate TUSC3 protein levels PMID: 28288641
8. Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma PMID: 27994502
9. TUSC3 regulates proliferation and invasion of glioblastoma cells by inhibiting the activity of the Akt signaling pathway. PMID: 27177902
10. decreased immunological TUSC3 staining is a factor prognostic of poor survival in pancreatic cancer patients. PMID: 26871953
11. The TUSC3 gene is associated with mental retardation in the Qinba mountain area in China; the sixth exon of the TUSC3 gene may contribute to the risk of developing the disease. PMID: 25966277
12. Report frequencies of short tandem repeat markers linked to TUSC3 (MRT7) or NSUN2 (MRT5) genes used for homozygosity mapping of recessive intellectual disability. PMID: 26427135
13. TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo PMID: 24435307
14. Loss of TUSC3 alters the molecular response to endoplasmic reticulum stress. PMID: 25735931
15. IGFII and N33 methylation status may be related to gastric carcinogenesis. PMID: 25086101
16. TUSC3 increases glycosylation efficiency for a subset of human glycoproteins by slowing glycoprotein folding. PMID: 24685145
17. Homozygous deletion in TUSC3 causes syndromic intellectual disability. PMID: 23825019
18. TUSC3 is a tumor suppressor gene in ovarian cancer. PMID: 23404293
19. Genotyping and linkage analysis excluded linkage of the GRIK2 gene and TUSC3 gene with mental retardation. PMID: 21557188
20. A novel nonsense mutation in TUSC3 is responsible for non-syndromic autosomal recessive mental retardation PMID: 21739581
21. analysis of a novel deletion mutation in the TUSC3 gene in a consanguineous Pakistani family that may have a role in autosomal recessive nonsyndromic intellectual PMID: 21513506
22. These findings suggest that inactivation through methylation of the putative tumor suppressor genes N-33 may not be associated with colorectal carcinogenesis in UC. PMID: 20505342
23. Down regulated in ovarian cancer or absent in ovarian cancer and impact survival. PMID: 16270321
24. N33, STK11 (19p13) and TP53 might play a role in the development of metastasis in larynx and pharynx squamous cell carcinomas. PMID: 17641416
25. TUSC3 is only the fifth gene implicated in NS-ARMR and the first for which mutations have been reported in more than one family. PMID: 18452889
26. study shows that mutations in two OTase-subunit genes, N33/TUSC3 and IAP result in autosomal-recessive nonsyndromic mental retardation PMID: 18455129
27. Knockdown of either MagT1 or TUSC3 protein significantly lowers the total and free intracellular Mg(2+) concentrations in cell lines. PMID: 19717468

Show More

Hide All

HGNC: 30242

OMIM: 601385

KEGG: hsa:7991

STRING: 9606.ENSP00000221167

UniGene: Hs.426324